[HTML][HTML] Tissue engineering and regenerative medicine: achievements, future, and sustainability in Asia
F Han, J Wang, L Ding, Y Hu, W Li, Z Yuan… - … in bioengineering and …, 2020 - frontiersin.org
Exploring innovative solutions to improve the healthcare of the aging and diseased
population continues to be a global challenge. Among a number of strategies toward this …
population continues to be a global challenge. Among a number of strategies toward this …
Concise review: laying the groundwork for a first-in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury
O Tsuji, K Sugai, R Yamaguchi, S Tashiro… - Stem …, 2019 - academic.oup.com
There have been numerous attempts to develop stem cell transplantation approaches to
promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently …
promote the regeneration of spinal cord injury (SCI). Our multicenter team is currently …
[HTML][HTML] Cell therapy for spinal cord injury using induced pluripotent stem cells
For the past few decades, spinal cord injury (SCI) has been believed to be an incurable
traumatic condition, but with recent developments in stem cell biology, the field of …
traumatic condition, but with recent developments in stem cell biology, the field of …
In vitro modeling of the bipolar disorder and schizophrenia using patient-derived induced pluripotent stem cells with copy number variations of PCDH15 and RELN
T Ishii, M Ishikawa, K Fujimori, T Maeda, I Kushima… - Eneuro, 2019 - eneuro.org
Bipolar disorder (BP) and schizophrenia (SCZ) are major psychiatric disorders, but the
molecular mechanisms underlying the complicated pathologies of these disorders remain …
molecular mechanisms underlying the complicated pathologies of these disorders remain …
[HTML][HTML] Oligodendrocytes in human induced pluripotent stem cell-derived cortical grafts remyelinate adult rat and human cortical neurons
R Martinez-Curiel, L Jansson, O Tsupykov, N Avaliani… - Stem Cell Reports, 2023 - cell.com
Neuronal loss and axonal demyelination underlie long-term functional impairments in
patients affected by brain disorders such as ischemic stroke. Stem cell-based approaches …
patients affected by brain disorders such as ischemic stroke. Stem cell-based approaches …
[HTML][HTML] Modeling Parkinson's disease using patient-specific induced pluripotent stem cells
Parkinson's disease (PD) is the second most common neurodegenerative disorder. It is
characterized by the degeneration of nigral dopaminergic (DA) neurons. While over 90% of …
characterized by the degeneration of nigral dopaminergic (DA) neurons. While over 90% of …
[HTML][HTML] Chromatin remodeler CHD7 targets active enhancer region to regulate cell type-specific gene expression in human neural crest cells
T Sanosaka, H Okuno, N Mizota, T Andoh-Noda… - Scientific reports, 2022 - nature.com
A mutation in the chromatin remodeler chromodomain helicase DNA-binding 7 (CHD7)
gene causes the multiple congenital anomaly CHARGE syndrome. The craniofacial …
gene causes the multiple congenital anomaly CHARGE syndrome. The craniofacial …
[HTML][HTML] Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases
K Sugai, R Fukuzawa, T Shofuda, H Fukusumi… - Molecular brain, 2016 - Springer
The risk of tumorigenicity is a hurdle for regenerative medicine using induced pluripotent
stem cells (iPSCs). Although teratoma formation is readily distinguishable, the malignant …
stem cells (iPSCs). Although teratoma formation is readily distinguishable, the malignant …
[HTML][HTML] Postsynaptic structure formation of human iPS cell-derived neurons takes longer than presynaptic formation during neural differentiation in vitro
K Togo, H Fukusumi, T Shofuda, H Ohnishi… - Molecular Brain, 2021 - Springer
The generation of mature synaptic structures using neurons differentiated from human-
induced pluripotent stem cells (hiPSC-neurons) is expected to be applied to physiological …
induced pluripotent stem cells (hiPSC-neurons) is expected to be applied to physiological …
[HTML][HTML] Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
M Isoda, T Sanosaka, R Tomooka, Y Mabuchi… - Communications …, 2023 - nature.com
Although neural stem/progenitor cells derived from human induced pluripotent stem cells
(hiPSC-NS/PCs) are expected to be a cell source for cell-based therapy, tumorigenesis of …
(hiPSC-NS/PCs) are expected to be a cell source for cell-based therapy, tumorigenesis of …